Cardinal Health Q4 earnings exceeded expectations, driven by increased pharmaceutical sales and sales growth.

Cardinal Health Inc reported better-than-expected Q4 earnings, with a 29% year-over-year increase in adjusted EPS to $1.84, driven by robust pharmaceutical sales. The healthcare services provider's sales increased by 12% to $59.87bn. In response, Cardinal Health raised its full-year profit guidance and share repurchase plan, projecting full-year adjusted EPS to range between $7.55 and $7.70.